| This article has been cited by | | 1 | Mammary serine protease inhibitor and CD138 immunohistochemical expression in ovarian serous and clear cell carcinomas | | | Eiman Adel Hasby | | Tumor Biology.2016;37(4)4889 | | [DOI] | | | 2 | The Comparative Study of the Frequency of P53 and Ki67 Markers in Ovarian Epithelial Tumors and Their Relationship with Survival in Patients Presenting to Shahid Sadoughi Hospital of Yazd in 2013–2017 | | | Shokouh Taghipour Zahir,Hedeye Nahangi,Koorosh Rahmani,Ezatollah Aalipour,Mohammad Baghi Yazdi | | Indian Journal of Gynecologic Oncology.2018;16(2)4889 | | [DOI] | | | 3 | Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer | | | Surrin S. Deen,Andrew N. Priest,Mary A. McLean,Andrew B. Gill,Cara Brodie,Robin Crawford,John Latimer,Peter Baldwin,Helena M. Earl,Christine Parkinson,Sarah Smith,Charlotte Hodgkin,Ilse Patterson,Helen Addley,Susan Freeman,Penny Moyle,Mercedes Jimenez-Linan,Martin J. Graves,Evis Sala,James D. Brenton,Ferdia A. Gallagher | | Scientific Reports.2019;9(1)4889 | | [DOI] | | | 4 | A cross-sectional study of immunohistochemical evaluation of surface epithelial ovarian tumors | | | Vikas Pandey,Jyotirmayee Mishra,PralhadS Potdar | | MGM Journal of Medical Sciences.2022;9(1)84 | | [DOI] | |
|
|
|
